vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and MASIMO CORP (MASI). Click either name above to swap in a different company.
American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $371.5M, roughly 1.5× MASIMO CORP). American Healthcare REIT, Inc. runs the higher net margin — 1.9% vs -27.0%, a 28.9% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs -26.4%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs -17.7%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.
AHR vs MASI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $371.5M |
| Net Profit | $10.8M | $-100.4M |
| Gross Margin | 14.8% | 62.1% |
| Operating Margin | 19.8% | 22.5% |
| Net Margin | 1.9% | -27.0% |
| Revenue YoY | 13.5% | -26.4% |
| Net Profit YoY | 133.9% | -1124.5% |
| EPS (diluted) | $0.07 | $-1.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | — | ||
| Q3 25 | $532.1M | $371.5M | ||
| Q2 25 | $501.3M | $370.9M | ||
| Q1 25 | $497.2M | $372.0M | ||
| Q4 24 | $496.8M | $600.7M | ||
| Q3 24 | $476.8M | $504.6M | ||
| Q2 24 | $458.0M | $496.3M | ||
| Q1 24 | $452.1M | $492.8M |
| Q4 25 | $10.8M | — | ||
| Q3 25 | $55.9M | $-100.4M | ||
| Q2 25 | $9.9M | $51.3M | ||
| Q1 25 | $-6.8M | $-170.7M | ||
| Q4 24 | $-31.8M | $-349.6M | ||
| Q3 24 | $-4.1M | $9.8M | ||
| Q2 24 | $2.0M | $16.0M | ||
| Q1 24 | $-3.9M | $18.9M |
| Q4 25 | 14.8% | — | ||
| Q3 25 | 14.6% | 62.1% | ||
| Q2 25 | 15.0% | 62.9% | ||
| Q1 25 | 13.0% | 62.9% | ||
| Q4 24 | 13.3% | 40.7% | ||
| Q3 24 | 12.5% | 52.2% | ||
| Q2 24 | 12.1% | 51.3% | ||
| Q1 24 | 10.7% | 49.0% |
| Q4 25 | 19.8% | — | ||
| Q3 25 | 19.9% | 22.5% | ||
| Q2 25 | 20.6% | 17.4% | ||
| Q1 25 | 19.0% | 21.0% | ||
| Q4 24 | 20.0% | -59.8% | ||
| Q3 24 | 19.6% | 6.0% | ||
| Q2 24 | 19.4% | 5.7% | ||
| Q1 24 | 18.2% | 6.9% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 10.5% | -27.0% | ||
| Q2 25 | 2.0% | 13.8% | ||
| Q1 25 | -1.4% | -45.9% | ||
| Q4 24 | -6.4% | -58.2% | ||
| Q3 24 | -0.9% | 1.9% | ||
| Q2 24 | 0.4% | 3.2% | ||
| Q1 24 | -0.9% | 3.8% |
| Q4 25 | $0.07 | — | ||
| Q3 25 | $0.33 | $-1.84 | ||
| Q2 25 | $0.06 | $0.94 | ||
| Q1 25 | $-0.04 | $-3.12 | ||
| Q4 24 | $-0.23 | $-6.54 | ||
| Q3 24 | $-0.03 | $0.18 | ||
| Q2 24 | $0.01 | $0.29 | ||
| Q1 24 | $-0.04 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $312.3M |
| Total DebtLower is stronger | — | $559.1M |
| Stockholders' EquityBook value | $3.3B | $810.0M |
| Total Assets | $5.4B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | — | ||
| Q3 25 | $147.4M | $312.3M | ||
| Q2 25 | $133.5M | $149.6M | ||
| Q1 25 | $86.1M | $130.8M | ||
| Q4 24 | $76.7M | $177.6M | ||
| Q3 24 | $67.8M | $158.5M | ||
| Q2 24 | $52.1M | $129.6M | ||
| Q1 24 | $77.0M | $157.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $559.1M | ||
| Q2 25 | — | $613.7M | ||
| Q1 25 | — | $651.0M | ||
| Q4 24 | — | $765.2M | ||
| Q3 24 | — | $772.6M | ||
| Q2 24 | — | $781.6M | ||
| Q1 24 | — | $876.0M |
| Q4 25 | $3.3B | — | ||
| Q3 25 | $2.7B | $810.0M | ||
| Q2 25 | $2.4B | $1.0B | ||
| Q1 25 | $2.3B | $946.4M | ||
| Q4 24 | $2.3B | $1.1B | ||
| Q3 24 | $2.2B | $1.5B | ||
| Q2 24 | $1.9B | $1.4B | ||
| Q1 24 | $2.0B | $1.4B |
| Q4 25 | $5.4B | — | ||
| Q3 25 | $4.8B | $1.8B | ||
| Q2 25 | $4.5B | $2.4B | ||
| Q1 25 | $4.5B | $2.3B | ||
| Q4 24 | $4.5B | $2.6B | ||
| Q3 24 | $4.7B | $3.1B | ||
| Q2 24 | $4.6B | $2.9B | ||
| Q1 24 | $4.7B | $3.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.64× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $56.8M |
| Free Cash FlowOCF − Capex | — | $50.9M |
| FCF MarginFCF / Revenue | — | 13.7% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 5.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $191.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | — | ||
| Q3 25 | $107.2M | $56.8M | ||
| Q2 25 | $71.5M | $69.4M | ||
| Q1 25 | $60.6M | $31.1M | ||
| Q4 24 | $59.5M | $50.5M | ||
| Q3 24 | $63.1M | $25.6M | ||
| Q2 24 | $59.4M | $74.5M | ||
| Q1 24 | $-6.0M | $45.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $50.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $28.5M | ||
| Q4 24 | — | $46.0M | ||
| Q3 24 | — | $16.9M | ||
| Q2 24 | — | $66.9M | ||
| Q1 24 | — | $37.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | — | 17.7% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 7.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | 5.12× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 7.21× | 1.35× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | 30.02× | 4.66× | ||
| Q1 24 | — | 2.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
MASI
Segment breakdown not available.
